Karolinska Institutet

Karolinska Institutet (KI) is one of the world’s leading medical research universities and biomedical research institutions, dedicated to advancing knowledge in medicine, healthcare, and life sciences. Founded in 1810 and headquartered in Stockholm, Sweden, KI is internationally recognized for its contributions to medical research, education, and innovation.

The institute conducts extensive research across numerous biomedical fields, including cancer, neuroscience, immunology, genetics, infectious diseases, cardiovascular medicine, aging research, public health, and regenerative medicine. Its researchers work to understand disease mechanisms and develop improved methods for prevention, diagnosis, and treatment.

Karolinska Institutet operates advanced research facilities and collaborates with hospitals, universities, pharmaceutical companies, biotechnology organizations, and international scientific networks. Through its connection with Karolinska University Hospital, the institute combines scientific research with clinical expertise to support translational medicine.

KI researchers use modern technologies including genomics, molecular biology, bioinformatics, imaging, artificial intelligence, and precision medicine approaches to address major healthcare challenges.

The institute is also responsible for awarding the Nobel Prize in Physiology or Medicine through the Nobel Assembly at Karolinska Institutet, highlighting its global influence in medical science.

Karolinska Institutet follows high standards of research ethics, scientific quality, laboratory safety, and academic excellence. It supports thousands of researchers, students, and healthcare professionals from around the world.

With more than two centuries of medical research history, Karolinska Institutet remains one of the most influential institutions in biomedical science, contributing discoveries that shape the future of healthcare globally.